LPSN Form 144 Notice — 59,053 Vested Shares Proposed for Sale
Rhea-AI Filing Summary
LivePerson, Inc. filed a Form 144 notifying the proposed sale of 59,053 common shares held at Fidelity Brokerage Services. The filing states these shares were acquired on 09/23/2025 through restricted stock vesting as compensation and the intended sale date is approximately 09/24/2025. The reported aggregate market value of the shares is $37,711.25, while the issuer has 96,624,957 shares outstanding. No securities were reported sold by the same person in the past three months. The notice includes the standard attestation that the seller is not aware of undisclosed material adverse information about the issuer.
Positive
- Securities were acquired through restricted stock vesting, indicating equity-based compensation rather than an external purchase
- No securities sold in the past three months by the person for whose account the securities are to be sold, per the filing
Negative
- Proposed sale of 59,053 shares with an aggregate market value of $37,711.25, which represents insider liquidity being realized
- Sale planned one day after vesting (acquired 09/23/2025, approximate sale 09/24/2025), indicating rapid disposition of newly vested shares
Insights
TL;DR: Routine Form 144 disclosing a near-term sale of vested restricted stock; no recent sales reported and the filing includes standard attestations.
This Form 144 shows an insider-derived compensation event where 59,053 shares vested on 09/23/2025 and are proposed for sale the following day. The disclosure identifies the broker as Fidelity Brokerage Services and lists an aggregate market value of $37,711.25. Given the size relative to total outstanding shares (96,624,957), the sale appears operationally routine rather than market-moving. The filer certifies no undisclosed material adverse information. Impact is informational for monitoring insider liquidity but does not, by itself, indicate a change in company fundamentals.
TL;DR: The filing documents a standard post-vesting disposition under Rule 144 with required broker and certification details; procedural and compliant.
The entry documents that the securities were acquired via restricted stock vesting and the payment nature is listed as compensation, which is consistent with equity-based employee awards. The notice contains the attestation about lack of undisclosed material adverse information and references Rule 144 procedures. No prior sales in the past three months are reported, reducing aggregation concerns. From a governance standpoint, this is a routine disclosure fulfilling regulatory obligations.